Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes: SIGNIFICANCE FOR EFFECTIVENESS AS ANTICANCER DRUGS (original) (raw)

1. Home
2. A-Z Publications
3. Platinum Metals Review
4. Volume 52, Issue 1
5. Article

• Navigate this Journal
• About
• Browse issues

• ISSN: 0032-1400

• SIGNIFICANCE FOR EFFECTIVENESS AS ANTICANCER DRUGS

• Source: Platinum Metals Review,Volume 52, Issue 1, Jan 2008, p. 2 - 11

• DOI: https://doi.org/10.1595/147106708X255987

• • Published online: 01 Jan 2008

• Full-Text

• Abstract

• Full-Text

• Figures & Tables

• References (99)

• Cited By (268)

• Supplements

Abstract

Metal coordination compounds with ‘slow’metal-ligand exchange rates, comparable to those of cell division processes, often appear to be highly active in killing cancer cell lines. This is particularly marked in platinum and ruthenium complexes. Classical examples such as cisplatin, as well as very recent examples from the author’s and other work, will be discussed in detail, and in the context of the current knowledge of the mechanism of antitumour action. It is shown that even though much is known about the molecular mechanism of action of cisplatin, many challenging questions are left for future research. For the ruthenium anticancer drugs molecular mechanistic studies are only at the beginning. Mechanistic studies on both platinum and ruthenium compounds have, however, opened many new avenues of research that may lead to the design of completely new drugs.

© Johnson Matthey

Article metrics loading...

/content/journals/10.1595/147106708X255987

2008-01-01

2025-04-28

Full text loading...

/deliver/fulltext/pmr/52/1/PMR-52-1-Reedijk.html?itemId=/content/journals/10.1595/147106708X255987&mimeType=html&fmt=ahah

• Article Type: Research Article

Most Read This Month

Article

content/journals/pmr

Journal

5

3

false

en